Author:
Xu Dan,Li Feng,Zhang Mian,Zhang Ji,Liu Can,Hu Meng-yue,Zhong Ze-yu,Jia Ling-ling,Wang Da-wei,Wu Jie,Liu Li,Liu Xiao-dong
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Pharmacology,General Medicine
Reference46 articles.
1. Health NIO. Third Report of the National Cholesterol Education Program Expert Panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). NIH publication 2001; 1: 3670.
2. Yusuf S . MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20536 high-risk individuals: a randomised placebo-controlled trial. Commentary. Lancet 2002; 360: 7–22.
3. Haffner SM, Lehto S, Rönnemaa T, Pyörälä K, Laakso M . Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med 1998; 339: 229–34.
4. Eliasson B, Svensson AM, Miftaraj M, Jonasson JM, Eeg-Olofsson K, Sundell KA . Clinical use and effectiveness of lipid lowering therapies in diabetes mellitus — an observational study from the Swedish national diabetes register. PLoS One 2011; 6: e18744.
5. Colhoun HM, Betteridge DJ, Durrington PN, Hitman GA, W Neil HA, Livingstone SJ, et al. Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial. Lancet 2004; 364: 685–96.
Cited by
28 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献